Stay updated on Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.

Latest updates to the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedLocations have been added and organized under a unified Locations section, listing sites in Baden-Wurttemberg, Bavaria, Hesse, and Saxony. The previous state-specific location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check51 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this change does not alter study data, eligibility criteria, or publicly visible details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedDeleted the government funding notice that previously appeared on the page; this banner is not part of the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe screenshots show only minor formatting and layout adjustments to the Study Details page, with no changes to core data such as enrollment, status, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference4%

Stay in the know with updates to Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalating GEM333 in Acute Myeloid Leukemia Clinical Trial page.